Obiltoxaximab: First Global Approval

Title
Obiltoxaximab: First Global Approval
Authors
Keywords
Levofloxacin, Cynomolgus Monkey, Protective Antigen, Single Intravenous Dose, Healthy Adult Volunteer
Journal
DRUGS
Volume 76, Issue 7, Pages 823-830
Publisher
Springer Nature
Online
2016-04-16
DOI
10.1007/s40265-016-0577-0

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now